However, in breast cancer cell lines, where PIAS4 is overexpressed, it has been observed that PIAS4 preferentially binds SUMO2 to HDAC1, protecting it from ubiquitination and degradation, and promoting its expression and activity that is involved in cancer progression [194]. The gene discussed is PIAS4; the disease is breast carcinoma.